| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.27 | 3e-09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-08 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |